Heat shock protein peptide complex-96 (HSPPC-96) vaccination for recurrent glioblastoma: a phase II, single arm trial
- PMID: 24729070
- PMCID: PMC3984567
- DOI: 10.1093/neuonc/nou054
Heat shock protein peptide complex-96 (HSPPC-96) vaccination for recurrent glioblastoma: a phase II, single arm trial
Comment on
-
Is there a role for vaccine-based therapy in recurrent glioblastoma?Neuro Oncol. 2014 May;16(5):757. doi: 10.1093/neuonc/nou031. Neuro Oncol. 2014. PMID: 24733854 Free PMC article. No abstract available.
References
-
- Bloch O, Han SJ, Cha S, et al. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article. J Neurosurg. 2012;117:1032–1038. - PubMed
-
- Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190–198. - PubMed
-
- McGirt MJ, Chaichana KL, Gathinji M, et al. Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg. 2009;110:156–162. - PubMed
-
- Chamberlain MC. Treatment of glioblastoma with bevacizumab: has a new standard therapy been defined? CNS Drugs. 2011;25:815–818. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
